Graphjet begins sales but faces $22.8M losses, $51K cash and going‑concern warning

Graphjet Technology (NASDAQ: ENCP) - What's happening inside

Quick summary: management started limited production and recorded the first small product sales (side products) in June 2025, but the company is deep in losses, with a strained balance sheet, large related‑party and shareholder liabilities, material non‑cash stock/warrant compensation and a formal going‑concern warning.

Key facts and statistics

* Revenues: $49,316 for the three months and $49,316 for the nine months ended June 30, 2025 (first sales from side products starting June 2025).

* Cost of revenue: $76,005 (3-mo and 9-mo), producing a gross loss of ($26,689).

* Operating expenses (3 months): Total $20,872,011 - General & administrative $1,672,011; Share compensation expense $19,200,000.

* Loss from operations (3 months): ($20,898,700). Net loss (3 months): ($21,501,957).

* Losses (9 months): Loss from operations ($22,103,705); Net loss ($22,768,135).

* Cash: $51,314 at June 30, 2025 (down from $348,655 at Sept. 30, 2024). Net change in cash for nine months: down $297,341.

* Total assets: $1,891,021. Total liabilities: $20,934,354. Shareholders' deficit: ($19,043,333).

* Negative working capital: $15,705,766 (management discloses substantial doubt about going concern).

* Large non‑cash share/warrant items: $19.2M share compensation recognized (fair value of warrants issued to a shareholder); warrants outstanding increased to 533,801 (combined), weighted average exercise shown in table as $261.19 after certain adjustments.

* Significant liabilities: Provision for bonus $10,350,000; Payables to prior shareholders $3,010,125; Loans from third parties $607,253; Loans from a shareholder $502,633; Total current liabilities $16,108,179.

* Cash flow (9 months): Net cash used in operating activities ($1,813,635); net cash provided by financing activities $1,568,062.

* Governance / compliance: Nasdaq granted continued listing subject to meeting bid‑price and filing conditions; management committed to file outstanding 10‑Qs by mid‑September 2025. Company disclosed material weaknesses in internal controls and restated prior period amounts.

Positive aspects (income statement / operational)

* First product sales: The company began generating revenue (side products) in June 2025, a sign production capability and some market traction.

* R&D / IP: Company claims patented biomass process and patent‑pending graphene method - potentially defensible product differentiation and cost advantage using palm kernel shells.

* Capital support: Recent financings and related‑party loans provided working capital in the period (financing activities supplied $1.57M for nine months).

Negative aspects (income statement / financial health)

* Huge losses: Net loss of $22.8M for nine months, driven largely by a $19.2M non‑cash share compensation charge; operating losses are large relative to tiny revenue base ($49k).

* Low cash and negative working capital: Cash $51k and working capital deficit ~ $15.7M - high short‑term liquidity risk and dependence on new financing.

* Share‑based dilution / non‑cash expense: $19.2M share compensation (warrants) materially inflated operating loss; this is a recurring governance/compensation risk if repeated.

* Related‑party and shareholder debt: Multiple loans and payables to prior shareholders, conversions and settlements - concentrated creditor/exposure risk and potential conflicts.

* Provision for bonus: $10.35M remains on the balance sheet - a large contingent obligation relative to current cash and revenue.

* Restatements & internal control issues: The company restated prior period amounts, disclosed material weaknesses and inadequate controls - increases audit/regulatory risk and reduces investor confidence.

What to watch next (near term catalysts & risks)

* Liquidity events: Fundraising, equity issuances, or loan rollovers - necessary to avoid insolvency risk given negative working capital.

* Commercial ramp: Successful qualification of product with multinational battery/graphite customers (qualification timelines 12-18 months are cited).

* Nasdaq conditions: Compliance with the Bid Price Rule and Periodic Filing Rule (deadlines set by Nasdaq) - failure could trigger delisting risk.

* Execution on IP / cost profile: Demonstrable lower cost and quality parity vs incumbent graphite suppliers would be the fundamental path to scaling revenue.

Bottom line: Graphjet Technology (NASDAQ: ENCP) owns potentially valuable biomass‑based graphite/graphene IP and has begun limited sales, but today it's a pre‑commercial company with very low cash, heavy losses (largely from a one‑time equity valuation charge), large related‑party liabilities, material control weaknesses and a disclosed going‑concern. Investors need to see meaningful financing, cleaner governance, and customer qualification progress before the investment thesis can be judged viable.

Source: Graphjet Technology Form 10‑Q for quarter ended June 30, 2025 (financials and notes summarized above).